[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"cancer-active-cancer-meaning-not-being-cancer-free-of-any-stage-and-involving-any-treatmentcare-regimen-ie-curative-life-extending-or-palliative\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:cancer-active-cancer-meaning-not-being-cancer-free-of-any-stage-and-involving-any-treatmentcare-regimen-ie-curative-life-extending-or-palliative":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,42],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100638678","is-the-1939-cancer-act-fit-for-purpose-in-the-modern-technology-era-100638678",false,"NCT07584824","Is the 1939 Cancer Act Fit for Purpose in the Modern Technology Era?","Inclusion Criteria:\n\nPatients\u002FRelatives:\n\n* UK residents (England and Wales ONLY).\n* Have been treated for a cancer within the last three years.\n* Aged 18 or over.\n* Can complete the survey themselves or have it completed on their behalf by a friend or family member (with the patient's permission).\n\nHealthcare Professionals:\n\n* UK-based professionals in the healthcare industry.\n* Working with patients diagnosed with cancer.\n* Consulting with patients at least once a month or more frequently.\n* Aged 18 or over.\n\nExclusion Criteria:\n\nNo explicit exclusion criteria are defined within provided materials, therefore any individual not meeting the inclusion criteria will be excluded.",true,"ALL","18 Years",{"count":19,"type":20},50,"ESTIMATED","OBSERVATIONAL","The 1939 Cancer Act in the UK (England \\& Wales) prohibits advertising of cancer treatments to the public, by anyone but the NHS. The rise of the internet and social media presents new challenges to its enforcement and raises questions about unintended consequences for patients being treated for cancer.\n\nThrough anonymous surveys, this study aims to understand how patients, healthcare professionals and industry professionals perceive technological changes and their implications for online and social media cancer care information, as well as highlight opportunities for safe and ethical modernisation.",[24,25,26,27,28],"Cancer","Cancer (Active Cancer, Meaning Not Being Cancer Free), of Any Stage and Involving Any Treatment\u002FCare Regimen; i.e. Curative, Life-extending, or Palliative","Cancer (Solid Tumors)","Cancer (With or Without Metastasis)","Cancer (Advanced Stage)","RECRUITING","2026-05-07",{"date":32,"type":33},"2026-05-13","ACTUAL",{"date":35,"type":33},"2026-01-09",{"date":37,"type":20},"2026-05-30",{"name":39,"class":40},"Royal Cornwall Hospitals Trust","OTHER",1,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":48,"eligibilityCriteria":49,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":50,"targetDuration":52,"studyType":21,"phases":4,"briefSummary":53,"conditions":54,"keywords":57,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":71},"100626286","wellspan-thrive-cancer-qol-study-100626286","NCT07433660","WellSpan-THRIVE Cancer QOL Study","WellSpan Study of Tracking Health and Resilience to Improve the Vitality of Individuals Experiencing Cancer [WellSpan-THRIVE]","THRIVE","Inclusion Criteria:\n\n* Age 18 years and above\n* Primary cancer diagnosis (newly diagnosed within the past 6 months)\n* Able to sign informed consent.\n\nExclusion Criteria:\n\n* Patients with age\\\u003C18 years,\n* Patients with primary non-melanoma skin, neurological malignancies (Brain or brain metastases), and primary hematological malignancies.\n* Patients with severe cognitive impairment, unable to sign informed consent or unable to complete quality of life questionnaire.\n* Patients with life expectancy of \\\u003C90 days, in the opinion of treating investigator.",{"count":51,"type":20},1000,"24 Months","Cancer affects millions of people worldwide and can significantly impact not only survival, but also day-to-day quality of life. Treatments such as surgery, chemotherapy, and radiation can cause side effects like fatigue, pain, and neuropathy, which may affect physical function, emotional well-being, and social relationships. While many studies have examined factors that influence quality of life; such as age, type and stage of cancer, and treatment-related symptoms; there is still a need for tools that more fully reflect patients' lived experiences.\n\nThis study aims to develop and implement a patient-centered quality of life (QOL) survey designed specifically for individuals with cancer. By directly involving patients in sharing what matters most to them, the survey seeks to provide a more complete and accurate understanding of how cancer and its treatment affect daily life. The results will help patients, families, and healthcare providers better identify needs, guide supportive care, and improve overall well-being throughout the cancer journey.",[25,26,27,55,56,28],"Cancer - Ovarian","Cancer Abdomen",[24,58,59,60,61],"Quality of Life","QOL","Registry","Patient","2026-02-26",{"date":64,"type":33},"2026-03-02",{"date":66,"type":20},"2026-02",{"date":68,"type":20},"2031-12",{"name":70,"class":40},"WellSpan Health",5]